Absci Corp (ABSI) Stock Price, Quote & News

Company Profile

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 360 949 1041

Website: www.absci.com

Address:

18105 SE Mill Plain Boulevard, Vancouver, United States

123diamondhands Oct. 25 at 1:08 PM

$ABSI https://investors.absci.com/events/event-details/abs-201-kol-seminar-anti-prlr-androgenetic-alopecia-program

0 · Reply

BEATOFtheMARKET Oct. 24 at 9:44 PM

$ABG $ABM $ABNY $ABSI $ABT 10/10 to 10/24 List Results 🔥 Cycle Trading Signal plugged into AI 🔥

0 · Reply

ProfessorGamma Oct. 24 at 8:19 PM

How much volume do you think it takes to gap CMCT up? CMCT has not even 700K shares float and recent news. Hoping for a 100% run on CMCT $LUNR $DUOL $ASPI $ABSI Wl--

0 · Reply

UncleTrump Oct. 24 at 6:52 PM

$ABSI

0 · Reply

UncleTrump Oct. 24 at 6:52 PM

$ABSI

0 · Reply

7m3835d3 Oct. 24 at 6:16 PM

$ABSI this seems unnecessary

0 · Reply

Cancercrusader Oct. 24 at 4:36 PM

$ABSI All the bald fatties can now get skinny and have a full head of hair. Now they just need a pill for charisma 😂

1 · Reply

Kennynails Oct. 24 at 11:13 AM

$RXRX $ABSI Super bullishon both.Just buy hold make a shietload of money how easy is that?

0 · Reply

Invest2live Oct. 23 at 3:54 PM

$NOK 43% already; congrats 🎊 🌿🎉 Check out $RXRX and $ABSI; excellent opportunity for longs

0 · Reply

flam70 Oct. 23 at 3:27 PM

$ABSI volume seems much less convicted on down days. Positive sign?

1 · Reply

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Sep 11, 2025, 12:10 PM EDT - 6 weeks ago

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

AMD ORCL

Sep 11, 2025, 8:00 AM EDT - 6 weeks ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 9, 2025, 12:13 AM EDT - 6 weeks ago

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 25, 2025, 4:05 PM EDT - 2 months ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 20, 2025, 8:00 AM EDT - 2 months ago

Absci to Participate in Upcoming Investor Conferences

Aug 13, 2025, 12:25 AM EDT - 2 months ago

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 2 months ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 7, 2025, 2:00 AM EDT - 2 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Jul 30, 2025, 4:05 PM EDT - 3 months ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 25, 2025, 8:34 AM EDT - 3 months ago

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

ASTS INTC

Jul 24, 2025, 8:45 PM EDT - 3 months ago

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 3 months ago

Absci Announces Proposed Public Offering of Common Stock

Jul 7, 2025, 8:00 AM EDT - 3 months ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

May 13, 2025, 10:45 PM EDT - 5 months ago

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 5 months ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:01 PM EDT - 5 months ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Apr 14, 2025, 4:05 PM EDT - 6 months ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 3, 2025, 3:15 PM EDT - 7 months ago

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Mar 19, 2025, 8:15 AM EDT - 7 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Mar 18, 2025, 7:37 PM EDT - 7 months ago

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:05 PM EDT - 7 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 4, 2025, 4:05 PM EST - 8 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:00 PM EST - 8 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 4, 2025, 8:00 AM EST - 8 months ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Feb 18, 2025, 8:00 AM EST - 8 months ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Jan 22, 2025, 1:22 PM EST - 9 months ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Jan 22, 2025, 8:00 AM EST - 9 months ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 13, 2025, 2:05 AM EST - 10 months ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Jan 10, 2025, 7:30 AM EST - 10 months ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 10 months ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 6, 2025, 8:00 AM EST - 10 months ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Nov 12, 2024, 10:01 AM EST - 1 year ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 7:30 AM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 3, 2024, 12:36 PM EDT - 1 year ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Aug 16, 2024, 11:50 PM EDT - 1 year ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Jul 28, 2024, 1:24 AM EDT - 1 year ago

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

May 28, 2024, 8:00 AM EDT - 1 year ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 14, 2024, 1:30 PM EDT - 1 year ago

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

May 14, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 1, 2024, 4:01 PM EST - 1 year ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Feb 21, 2024, 7:30 AM EST - 1 year ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Jan 10, 2024, 7:30 AM EST - 1 year ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 3, 2024, 8:00 AM EST - 1 year ago

Absci to Participate in the 26th Annual Needham Growth Conference

123diamondhands Oct. 25 at 1:08 PM

$ABSI https://investors.absci.com/events/event-details/abs-201-kol-seminar-anti-prlr-androgenetic-alopecia-program

0 · Reply

BEATOFtheMARKET Oct. 24 at 9:44 PM

$ABG $ABM $ABNY $ABSI $ABT 10/10 to 10/24 List Results 🔥 Cycle Trading Signal plugged into AI 🔥

0 · Reply

ProfessorGamma Oct. 24 at 8:19 PM

How much volume do you think it takes to gap CMCT up? CMCT has not even 700K shares float and recent news. Hoping for a 100% run on CMCT $LUNR $DUOL $ASPI $ABSI Wl--

0 · Reply

UncleTrump Oct. 24 at 6:52 PM

$ABSI

0 · Reply

UncleTrump Oct. 24 at 6:52 PM

$ABSI

0 · Reply

7m3835d3 Oct. 24 at 6:16 PM

$ABSI this seems unnecessary

0 · Reply

Cancercrusader Oct. 24 at 4:36 PM

$ABSI All the bald fatties can now get skinny and have a full head of hair. Now they just need a pill for charisma 😂

1 · Reply

Kennynails Oct. 24 at 11:13 AM

$RXRX $ABSI Super bullishon both.Just buy hold make a shietload of money how easy is that?

0 · Reply

Invest2live Oct. 23 at 3:54 PM

$NOK 43% already; congrats 🎊 🌿🎉 Check out $RXRX and $ABSI; excellent opportunity for longs

0 · Reply

flam70 Oct. 23 at 3:27 PM

$ABSI volume seems much less convicted on down days. Positive sign?

1 · Reply

LeronLegend_Visionary Oct. 22 at 5:53 PM

$ABSI We attracted some parasites last week! They are about to lose their wings soon. Insider tracking services (e.g., MarketBeat, Benzinga) show no sales reported in the last 30 days for ABSI. 1) The most recent insider transactions listed are purchases: 2) Menelas N. Pangalos (Director) bought 95,785 shares on 9/22/2025. 3) Todd Bedrick (SVP & CAO) bought 10,000 shares on 9/22/2025. Take that and Prove otherwise Bashers.

0 · Reply

LeronLegend_Visionary Oct. 22 at 5:27 PM

$ABSI Insiders and institutions are NOT SELLING. Ignore the Fud…. The last post should be reported! https://fintel.io/sn/us/absi https://fintel.io/so/us/absi

0 · Reply

UncleTrump Oct. 22 at 3:15 PM

$ABSI

0 · Reply

healthcareguru Oct. 22 at 2:44 PM

$ABSI 😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂

0 · Reply

7m3835d3 Oct. 22 at 1:44 PM

$ABSI time to drop the data or pharma collab news, before this plummets below $4 again

0 · Reply

UncleTrump Oct. 21 at 6:58 PM

$ABSI If you are bald or going to be one soon, this is the perfect stock to invest on . LFG balds.

1 · Reply

7m3835d3 Oct. 21 at 1:50 PM

$ABSI So we are back to the pump-and-dump behavior until the next news comes out. Except this time it happens around $4.50 - 5, not in the $2.50 - 3 range, so I'll take that!

0 · Reply

flam70 Oct. 21 at 8:57 AM

$ABSI https://www.linkedin.com/posts/sean-mcclain_hair-isnt-just-about-appearance-its-about-share-7386201277329948672-s3g6?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAANo6pQBCIF-Wc4f2krmT0uqAEWRN9CcBfE&utm_campaign=whatsapp

0 · Reply

PeelonDusk Oct. 20 at 5:32 PM

$ABSI

0 · Reply

7m3835d3 Oct. 20 at 2:27 PM

$ABSI great start to the week!

0 · Reply

Jandy244 Oct. 20 at 2:10 AM

$ABSI watching for entry around 4.25

1 · Reply

musky54 Oct. 17 at 8:01 PM

$ABSI a little recovery, big volume last 15 minutes

0 · Reply

Market Cap	638.46M
Revenue (ttm)	4.53M
Net Income (ttm)	-103.11M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,276.16%
Debt to Equity Ratio	0.01

Volume	3,643,200
Avg Vol	5,458,828
Day's Range	N/A - N/A
Shares Out	149.52M
Stochastic %K	46%
Beta	2.06
Analysts	Strong Sell
Price Target	$8.13